Kaempferol and Esculetin as Potential Therapeutic Agents in Chronic Renal Allograft Injury
<p> Although chronic allograft damage (CAD) remains a primary barrier to long-term renal allograft survival, limited progress has been made in the discovery of potential therapeutics. In order to identify potential drug therapies, we used two meta-analytical methods to evaluate six post-renal...
Main Author: | Greene, Ilana |
---|---|
Language: | EN |
Published: |
Icahn School of Medicine at Mount Sinai
2015
|
Subjects: | |
Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=1595299 |
Similar Items
-
DEVELOPMENTS OF LIPID-BASED NANOPARTICLES FOR THERAPEUTIC DRUG DELIVERY
by: Zhang, Mengzi
Published: (2014) -
A Systematic Investigation of the Sulfation of Esculetin by the Human Cytosolic Sulfotransferases (SULTs)
by: Alatwi, Eid
Published: (2017) -
Discovery of sulfone-resistant dihydropteroate synthase (DHPS) as a target enzyme for kaempferol, a natural flavanoid
by: Angamba Meetei Potshangbam, et al.
Published: (2020-02-01) -
Therapeutic Drug Monitoring of Apixaban Using Chromogenic Kits
by: Vogel, Brooke
Published: (2020) -
Computational Biology: Modeling Chronic Renal Allograft Injury
by: Mark D Stegall, et al.
Published: (2015-08-01)